Ralph Santos-Oliveira

Dr. Ralph Santos-Oliveira

Laboratory of Radiopharmacy and Nano-Radiopharmaceuticals, Nuclear Engineering Institute, Rio de Janeiro, Brazil
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 September 2021 in Journal of Nanostructure in Chemistry
Verified
Journal Article
Closed access
PDF file
TMTais Monteiro Magne
Tais Monteiro Magne
TVThamires de Oliveira Vieira
Thamires de Oliveira Vieira
LALuciana Magalhães Rebelo Alencar
Luciana Magalhães Rebelo Alencar
FJFrancisco Franciné Maia Junior
Francisco Franciné Maia Junior
SGSara Gemini-Piperni
Sara Gemini-Piperni
RSRalph Santos-Oliveira
Ralph Santos-Oliveira

25 April 2022 in EJNMMI Radiopharmacy and Chemistry
Verified
Journal Article
Open access
PDF file
MPMartha Sahylí Ortega Pijeira
Martha Sahylí Ortega Pijeira
HVHerlys Viltres
Herlys Viltres
Ján KozempelJán Kozempel
Ján Kozempel
MSMichal Sakmár
Michal Sakmár
MVMartin Vlk
Martin Vlk
RSRalph Santos-Oliveira
Ralph Santos-Oliveira
Background: Recent advances in nanotechnology have offered new hope for cancer detection, prevention, and treatment. Nanomedicine, a term for the application of nanotechnology in medical and health fields, uses nanoparticles for several applications such as imaging, diagnostic, targeted cancer therapy, drug and gene delivery, tissue engineering, and theranostics.Results: Here, we overview the current state-of-the-art of radiolabeled nanoparticles for molecular imaging and radionuclide therapy. Nanostructured radiopharmaceuticals of technetium-99m, copper-64, lutetium-177, and radium-223 are discussed within the scope of this review article.Conclusion: Nanoradiopharmaceuticals may lead to better development of theranostics inspired by ingenious delivery and imaging systems. Cancer nano-theranostics have the potential to lead the way to more specific and individualized cancer treatment.Graphical

3 May 2024 in Advances in Colloid and Interface Science
Verified
Journal Article
Closed access
EAE.V. Araújo
E.V. Araújo
SCS.V. Carneiro
S.V. Carneiro
DNDavino Machado Andrade Neto
Davino Machado Andrade Neto
TFTiago Freire
Tiago Freire
VCV.M. Costa
V.M. Costa
PFPierre Fechine
Pierre Fechine

1 September 2019 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
FMFrederico Duarte de Menezes
Frederico Duarte de Menezes
SRSara Rhaissa Rezende dos Reis
Sara Rhaissa Rezende dos Reis
SPSuyene Rocha Pinto
Suyene Rocha Pinto
FPFilipe Leal Portilho
Filipe Leal Portilho
FMFrancisco Mello
Francisco Mello
RSRalph Santos-Oliveira
Ralph Santos-Oliveira

1 January 2020 in Drug Delivery
Verified
Journal Article
Open access
SWShentian Wu
Shentian Wu
EHEdward Helal-Neto
Edward Helal-Neto
AMAna Paula dos Santos Matos
Ana Paula dos Santos Matos
AJAmir Jafari
Amir Jafari
Ján KozempelJán Kozempel
Ján Kozempel
RSRalph Santos-Oliveira
Ralph Santos-Oliveira
Nowadays, emerging radiolabeled nanosystems are revolutionizing medicine in terms of diagnostics, treatment, and theranostics. These radionuclides include polymeric nanoparticles (NPs), liposomal carriers, dendrimers, magnetic iron oxide NPs, silica NPs, carbon nanotubes, and inorganic metal-based nanoformulations. Between these nano-platforms, polymeric NPs have gained attention in the biomedical field due to their excellent properties, such as their surface to mass ratio, quantum properties, biodegradability, low toxicity, and ability to absorb and carry other molecules. In addition, NPs are capable of carrying high payloads of radionuclides which can be used for diagnostic, treatment, and theranostics depending on the radioactive material linked. The radiolabeling process of nanoparticles can be performed by direct or indirect labeling process. In both cases, the most appropriate must be selected in order to keep the targeting properties as preserved as possible. In addition, radionuclide therapy has the advantage of delivering a highly concentrated absorbed dose to the targeted tissue while sparing the surrounding healthy tissues. Said another way, radioactive polymeric NPs represent a promising prospect in the treatment and diagnostics of cardiovascular diseases such as cardiac ischemia, infectious diseases such as tuberculosis, and other type of cancer cells or tumors.

22 November 2022 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
EGEsteban Leonardo Guamba
Esteban Leonardo Guamba
NVNelson Santiago Vispo
Nelson Santiago Vispo
DWDaniel Whitehead
Daniel Whitehead
Ajaya Kumar SinghAjaya Kumar Singh
Ajaya Kumar Singh
RSRalph Santos-Oliveira
Ralph Santos-Oliveira
Frank AlexisFrank Alexis
Frank Alexis
Hydrogels are promising candidates for wound healing bandages because they can mimic the native skin microenvironment. Additionally, there is increasing growth in the use of naturally derived materials and plant-based biomaterials to produce healthcare products with healing purposes because of their biocompatibility and biodegradation properties. In this study, cellulose extracted from biodiverse sources in Ecuador was used as the raw material for the fabrication of hydrogels with enhanced antifouling properties. Fourier-transform infrared (FTIR) spectroscopy, X-ray diffraction (XRD), and scanning electron microscopy (SEM) were used to characterize the cellulose and hydrogels. In vitro and ex vivo tests were performed to evaluate the antimicrobial activity of hydrogels against Gram-negative bacteria as a model. Finally, the hydrogel synthesized with cellulose extracted from pitahaya showed improved antibacterial activity when applied over pigskin as a proof of concept for wound dressing. Therefore, the present results suggest that cellulose-based hydrogels are good candidates for application as wound dressings.